Sign up to save your podcasts
Or
Share First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
3030 ratings
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
More shows like Lung Cancer Update
View all
Hidden Brain
43,693 Listeners
NEJM This Week
316 Listeners
This Week in Virology
2,061 Listeners
Breast Cancer Update
68 Listeners
Hematologic Oncology Update
73 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
120 Listeners
ASCO Daily News
58 Listeners
ASCO Guidelines
45 Listeners
Lung Cancer Considered
26 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Two Onc Docs
192 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
44 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners
Lung Cancer Rx
3 Listeners